Precision Bio Says USPTO Issues Final Claims Rejecting Infringement Allegations by Cellectis

Despite the decision by the USPTO, a Cellectis spokeswoman said little is changed in its patent infringement battle with Precision BioSciences.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.